Zandberg et al. , A phase I dose escalation trial of MAGE -A3- and HPV16 -specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN). Cancer immunology, i mmunotherapy : CII 64, 367 -379 (2015). 53. F. Faure et al. , Long -lasting cross -presentation of tumor antigen in human DC. European journal of immunology 39, 380 -390 (2009). 54. R. A. Rosalia et al. , Dendritic cells process synthetic long peptides better th an whole protein, improving antigen presentation and T -cell activation. European journal of immunology 43, 2554 - 2565 (2013). 55. M. A. Cheever, C.